{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:01:27Z","timestamp":1787900487379,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019992","name":"Glenmark Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.pharma.2022.08.010","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T11:11:20Z","timestamp":1661685080000},"page":"315-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: Formulation, optimization and pharmacological studies in rats"],"prefix":"10.1016","volume":"81","author":[{"given":"D.","family":"Gadhave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tagalpallewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2022.08.010_bib0305","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10717544.2014.914602","article-title":"Paliperidone microemulsion for nose-to-brain targeted drug delivery system: Pharmacodynamic and pharmacokinetic evaluation","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.pharma.2022.08.010_bib0310","series-title":"Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies","first-page":"20","author":"Gadhave","year":"2019"},{"key":"10.1016\/j.pharma.2022.08.010_bib0315","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1773-2247(13)50085-2","article-title":"Risperidone-loaded mucoadhesive microemulsion for intranasal delivery: formulation development, physicochemical characterization and ex vivo evaluation","volume":"23","author":"Patel","year":"2013","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0320","first-page":"9","article-title":"Neutropenia and leukopenia protective intranasal olanzapine-loaded lipid-based nanocarriers engineered for brain delivery","author":"Gadhave","year":"2019","journal-title":"Appl Nanosci"},{"key":"10.1016\/j.pharma.2022.08.010_bib0325","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pnpbp.2010.09.018","article-title":"Paliperidone-induced leukopenia and neutropenia: a case report","volume":"35","author":"Kim","year":"2011","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"10.1016\/j.pharma.2022.08.010_bib0330","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0004867412460594","article-title":"Risperidone\/paliperidone induced neutropenia and lymphopenia","volume":"47","author":"Raj","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pharma.2022.08.010_bib0335","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0278-5846(01)00258-5","article-title":"Olanzapine-induced agranulocytosis: a case report and review of the literature","volume":"26","author":"Tolosa-Vilella","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharma.2022.08.010_bib0340","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0004867418821441","article-title":"Acute agranulocytosis when switching from risperidone to paliperidone","volume":"53","author":"Wakuda","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pharma.2022.08.010_bib0345","doi-asserted-by":"crossref","first-page":"119499","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0350","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1016\/j.xphs.2019.08.027","article-title":"Analyzing nanotheraputics-based approaches for the management of psychotic disorders","volume":"108","author":"Annu","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2022.08.010_bib0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jddst.2019.02.013","article-title":"Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma","volume":"51","author":"Gadhave","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0360","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0365","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/03639045.2018.1526186","article-title":"Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation","volume":"45","author":"Ramreddy","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0370","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: An excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.pharma.2022.08.010_bib0375","doi-asserted-by":"crossref","first-page":"121050","DOI":"10.1016\/j.ijpharm.2021.121050","article-title":"Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: in vitro and in vivo pharmacological studies","author":"Gadhave","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0380","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2012.01.024","article-title":"Nasal drug delivery - Recent developments and future prospects","volume":"161","author":"Illum","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2022.08.010_bib0385","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.pharma.2022.08.010_bib0390","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijbiomac.2013.06.041","article-title":"Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery","volume":"61","author":"Kumar","year":"2013","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0395","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejpb.2008.10.009","article-title":"Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue","volume":"72","author":"Horv\u00e1t","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0400","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","article-title":"Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route","volume":"4","author":"Pathak","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.pharma.2022.08.010_bib0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejpb.2015.08.008","article-title":"Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid","volume":"96","author":"Shinde","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0410","doi-asserted-by":"crossref","first-page":"101954","DOI":"10.1016\/j.jddst.2020.101954","article-title":"Pramipexole thermosensitive nasal gel for experimental parkinsonism in rats","volume":"59","author":"Sridhar","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0415","doi-asserted-by":"crossref","first-page":"111076","DOI":"10.1016\/j.colsurfb.2020.111076","article-title":"Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation","volume":"193","author":"Hady","year":"2020","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.pharma.2022.08.010_bib0420","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijbiomac.2011.05.020","article-title":"Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles","volume":"49","author":"Sarmah","year":"2011","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0425","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijbiomac.2019.02.089","article-title":"Fabrication of dual network self-healing alginate\/guar gum hydrogels based on polydopamine-type microcapsules from mesoporous silica nanoparticles","volume":"129","author":"Rao","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0430","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijbiomac.2020.11.047","article-title":"Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies","volume":"167","author":"Gadhave","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0435","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijbiomac.2020.05.041","article-title":"Fabrication of multifunctional Guar gum-silver nanocomposite hydrogels for biomedical and environmental applications","volume":"159","author":"Reddy","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijbiomac.2014.11.007","article-title":"In situ generation of silver nanoparticles within crosslinked 3D guar gum networks for catalytic reduction","volume":"73","author":"Zheng","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0445","first-page":"0","article-title":"Guar gum: Versatile natural polymer for drug delivery applications","author":"George","year":"2018","journal-title":"Eur Polym J"},{"key":"10.1016\/j.pharma.2022.08.010_bib0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2013.08.024","article-title":"Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407","volume":"62","author":"Bhowmik","year":"2013","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0455","doi-asserted-by":"crossref","first-page":"101994","DOI":"10.1016\/j.jddst.2020.101994","article-title":"Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: An in vitro study on bacterial and hepatocellular carcinoma cells","volume":"60","author":"Das","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0460","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharma.2022.08.010_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2015.04.015","article-title":"Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity","author":"Pund","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0470","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.colsurfb.2014.06.037","article-title":"Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer","volume":"122","author":"Devkar","year":"2014","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.pharma.2022.08.010_bib0475","series-title":"Poloxamer 407 based-nanoparticles for controlled release of methotrexate","first-page":"575","author":"Noro","year":"2020"},{"key":"10.1016\/j.pharma.2022.08.010_bib0480","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12668-020-00767-5","article-title":"Poloxamer-based in situ nasal gel of naratriptan hydrochloride deformable vesicles for brain targeting","volume":"10","author":"Shelke","year":"2020","journal-title":"BioNanoScience"},{"key":"10.1016\/j.pharma.2022.08.010_bib0485","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40005-015-0212-1","article-title":"Neuroprotective effect of ibuprofen by intranasal application of mucoadhesive nanoemulsion in MPTP induced Parkinson model","volume":"46","author":"Mandal","year":"2016","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.pharma.2022.08.010_bib0490","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNF\u03b1 siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomedicine Nanotechnology Biol Med"},{"key":"10.1016\/j.pharma.2022.08.010_bib0495","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.colsurfb.2013.09.030","article-title":"Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment","volume":"113","author":"Sood","year":"2014","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.pharma.2022.08.010_bib0500","first-page":"32","article-title":"Development of near zero-order release PLGA-based microspheres of a novel antipsychotic","volume":"516","author":"Jinlong","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0505","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","article-title":"Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies","volume":"45","author":"Gadhave","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0510","doi-asserted-by":"crossref","first-page":"101301","DOI":"10.1016\/j.jddst.2019.101301","article-title":"Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery","volume":"54","author":"Choudhury","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0515","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10837450.2019.1659818","article-title":"Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and in vivo safety evaluation","volume":"25","author":"Kokare","year":"2020","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0520","first-page":"231","volume":"388","author":"Gannu","year":"2010","journal-title":"Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: Formulation optimization, ex vivo and in vivo characterization"},{"key":"10.1016\/j.pharma.2022.08.010_bib0525","first-page":"64","article-title":"Preparation and evaluation of transnasal microemulsion of carbamazepine","volume":"8","author":"Acharya","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.pharma.2022.08.010_bib0530","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10667857.2019.1674522","article-title":"Improved brain pharmacokinetics following intranasal administration of N,N, N-trimethyl chitosan tailored mucoadhesive NLCs","volume":"35","author":"Pardeshi","year":"2020","journal-title":"Mater Technol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0535","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","article-title":"Nose to Brain Delivery of Rivastigmine by In Situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics","volume":"106","author":"Wavikar","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharma.2022.08.010_bib0540","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1016\/j.biomaterials.2013.07.075","article-title":"Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment","volume":"34","author":"Cui","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharma.2022.08.010_bib0545","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0550","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17460441.2020.1682994","article-title":"The preclinical discovery and development of paliperidone for the treatment of schizophrenia","volume":"15","author":"Weso\u0142owska","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharma.2022.08.010_bib0555","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1039\/C5RA19793G","article-title":"Intranasal delivery of asenapine loaded nanostructured lipid carriers: Formulation, characterization, pharmacokinetic and behavioural assessment","volume":"6","author":"Dadhania","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.pharma.2022.08.010_bib0560","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.euroneuro.2015.01.006","article-title":"Asenapine alters the activity of monoaminergic systems following its subacute and long-term administration: An in vivo electrophysiological characterization","volume":"25","author":"Oosterhof","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2017.00295","article-title":"Dopamine and the brainstem locomotor networks: From lamprey to human","volume":"11","author":"Ryczko","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharma.2022.08.010_bib0570","first-page":"579","article-title":"Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease","author":"Bhattamisra","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2022.08.010_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(93)90036-D","article-title":"Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs","volume":"57","author":"Ellenbroek","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharma.2022.08.010_bib0580","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopha.2017.07.067","article-title":"Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study","volume":"94","author":"Pokharkar","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharma.2022.08.010_bib0585","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharma.2022.08.010_bib0590","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.pharma.2022.08.010_bib0595","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","article-title":"Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa","volume":"48","author":"Pund","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharma.2022.08.010_bib0600","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0024-3205(88)90551-6","article-title":"The paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism","volume":"42","author":"Ellenbroek","year":"1988","journal-title":"Life Sciences"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450922001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450922001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:38:58Z","timestamp":1757720338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450922001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0003450922001080"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2022.08.010","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: Formulation, optimization and pharmacological studies in rats","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2022.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}